(Q26783973)

English

Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV

scientific article

In more languages

Statements

scholarly article

0 references

2 references

29 May 2020

16 December 2020

systematic review

1 reference

PubMed publication ID

1 reference

PubMed publication ID

Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV (English)

0 references

uterine cervix neoplasm

1 reference

16 December 2020

Alphapapillomavirus

1 reference

3 November 2019

1 reference

PubMed publication ID

Papillomavirus infections

1 reference

16 December 2020

systematic review

1 reference

based on heuristic

inferred from title

Roberto D'Amico

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Simona Di Mario

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Vittorio Basevi

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Pier Luigi Lopalco

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Nicola Magrini

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

0 references

publication date

25 August 2015

8 references

13 March 2019

14 March 2019

23 March 2019

3 April 2019

20 June 2019

21 October 2019

3 November 2019

16 December 2020

Journal of Immunology Research

10 references

13 March 2019

14 March 2019

23 March 2019

3 April 2019

20 June 2019

21 October 2019

3 November 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

16 December 2020

2015

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

435141

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

copyright license

Creative Commons Attribution 3.0 Unported

9 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

14 March 2019

Europe PubMed Central

23 March 2019

Europe PubMed Central

3 April 2019

Europe PubMed Central

20 June 2019

Europe PubMed Central

21 October 2019

Europe PubMed Central

3 November 2019

Europe PubMed Central

29 May 2020

Europe PubMed Central

16 December 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

7 April 2017

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

7 April 2017

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

7 April 2017

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

7 April 2017

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

7 April 2017

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

25 May 2017

Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Getting more generous with the truth: clinical trial reporting in 2013 and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Efficacy and safety of human papilloma virus vaccine in cervical cancer prevention: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

From desire to disease: human papillomavirus (HPV) and the medicalization of nascent female sexuality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Prevalence and risk factors of HPV infection among women from various provinces of the world

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

The known unknowns of HPV natural history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Human papillomavirus: science and technologies for the elimination of cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

The Statistics of Anti-typhoid and Anti-cholera Inoculations, and the Interpretation of such Statistics in general

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Advances in prevention of cervical cancer and other human papillomavirus-related diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Worldwide burden of gynaecological cancer: the size of the problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

The promise of global cervical-cancer prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 September 2017

Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

31 May 2018

Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

31 May 2018

Prevalence and risk factors of high-risk human papillomavirus in female sex workers in Spain: differences by geographical origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

31 May 2018

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

31 May 2018

Epidemiology of Genital Human Papillomavirus Infection

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Clinical trial experience with prophylactic HPV 6/11/16/18 VLP vaccine in young women from the Asia-Pacific region

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24.

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology.

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Tendering and value-based pricing: lessons from Italy on human papilloma virus vaccines.

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Clinical trial data for all drugs in current use.

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F435141

21 January 2018

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562171

28 November 2018

UK will use Gardasil in its HPV vaccination programme from next September

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of human papillomavirus type 16/18 AS04-adjuvanted vaccine in Japanese women aged 20 to 25 years: final analysis of a phase 2 double-blind, randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human Papillomavirus Vaccination — Reasons for Caution

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HPV-beyond cervical cancer (online resource center)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The need to promote independent research on drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/26380321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2015/435141

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

release_6epn4skv5ffdbcjmr2lic35sb4

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26380321%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26783973&oldid=1951672342"